Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors

Keyphrases

• Stereotactic Ablative Radiotherapy 100%
• Ultra-central Lung Tumor 100%
• Central Tumor 60%
• Follow-up Time 40%
• Central Airways 40%
• Ultracentral 40%
• Tumor 20%
• Overall Survival 20%
• Median Overall Survival 20%
• Tumor Treatment 20%
• Non-small Cell Lung Cancer (NSCLC) 20%
• Treatment Plan 20%
• Lung Tumor 20%
• Local Failure 20%
• Treatment Toxicity 20%
• Tumor Patients 20%
• Dose Constraints 20%
• Peripheral Tumor 20%
• Pneumonitis 20%
• Dosimetric Analysis 20%
• Single Lung 20%
• Chest Wall Pain 20%
• Symptomatic Toxicity 20%
• Peripheral Lung Tumors 20%
• Ultraperipheral 20%

Medicine and Dentistry

• Lung Tumor 100%
• Radiation Therapy 100%
• Neoplasm 66%
• Overall Survival 33%
• Cancer Treatment 16%
• Thoracic Wall 16%
• Non-Small Cell Lung Cancer 16%
• Pneumonia 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Tumor 100%
• Neoplasm 83%
• Overall Survival 33%
• Pneumonia 16%